When was ALZpath founded?

ALZpath was founded in 2020 and raised its 1st funding round 3 years after it was founded.

Where is ALZpath located?

ALZpath is headquartered in Carlsbad, United States.

Who is the current CEO of ALZpath?

Venkat Shastri of ALZpath. They have also founded 1 company.

How many employees does ALZpath have?

As of Aug 31, 2026, the latest employee count at ALZpath is 10.

Is ALZpath a funded company?

ALZpath is a funded company, having raised a total of $8.41M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 18, 2023.

When was the latest funding round of ALZpath?

ALZpath's latest funding was a $***** Series A round on Jul 14, 2026, with participation from 0 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $4.84B in funding in 2026 to date.

Where does ALZpath rank among its competitors?

ALZpath ranks 3rd amongst 47 active competitors, of which 19 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was ALZpath, which secured $8.41M in Jul, 2026.

Who are the top competitors of ALZpath?

ALZpath's top competitors include NeuroDex, C₂N Diagnostics and Amydis Diagnostics. Among them, ALZpath secured the most recent funding round in July, 2026.

ALZpath - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of diagnostic solutions for Alzheimer's Disease. The company offers a novel blood-based biomarker assay for phosphorylated tau 217 (ptau217) that can identify Alzheimer's disease before symptoms appear.

Website: alzpath.bio
Social
Email ID: *****@alzpath.bio
Phone Number: +1 **********

Key Metrics

Founded Year

2020

Location

Carlsbad, United States

Stage

Series A

Total Funding

$8.41M in 2 rounds

Latest Funding Round

Series A, Jul 14, 2026, $*****

Investors

Stead Impact Ventures & 1 more

Ranked

3^rd among 47 active competitors

Employee Count

10 as on Aug 31, 2026

Similar Companies

NeuroDex & 60 more

View ALZpath's full profile

ALZpath is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
ALZPath Inc CIN: 851378458 , United States, Active	Dec 31, 2019	-	7 (As on Dec 31, 2024)	-

ALZpath has raised a total funding of $8.41M over 2 rounds. Its first funding round was on Jul 18, 2023. ALZpath has 2 institutional investors.

Here is the list of recent funding rounds of ALZpath:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 14, 2026	9748152	Series A	8183681	3209135	9818315	3439927
Jul 18, 2023	8606065	Seed	8695911	6556720	1077540	Alzheimer's Drug Discovery

Access funding benchmarks and valuations. Sign up today!

View details of ALZpath's funding rounds and investors

The founders of ALZpath are Jerre Stead, Eric Reiman and Venkat Shastri. Venkat Shastri is the CEO of ALZpath.

Here are the details of ALZpath's key team members:

Jerre Stead: Co-Founder of ALZpath. They serve on the board of 1 company.
Eric Reiman: Co-Founder of ALZpath.
Venkat Shastri: Co-Founder & CEO of ALZpath.
Contact Info: 1 email address

View details of ALZpath's Founder profiles and Board Members

ALZpath's employee count trend

ALZpath has 10 employees as of Aug 26. Here is ALZpath's employee count trend over the years:

Uncover ALZpath's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ALZpath include NeuroDex, C₂N Diagnostics and Amydis Diagnostics. Here is the list of Top 10 competitors of ALZpath, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NeuroDex 2018, Natick (United States), Seed	Manufacturer of diagnostic tools for Alzheimer's disease	$1.36M	ICV, Military Health & 1 others	60/100
2nd	C₂N Diagnostics 2007, St. Louis (United States), Series B	Developer of diagnostics and therapies for Alzheimer's disease	$35M	Eisai, Samsung Venture Investment & 6 others	58/100
3rd	ALZpath 2020, Carlsbad (United States), Series A	Developer of diagnostic solutions for Alzheimer's Disease	$8.41M	Stead Impact Ventures, Alzheimer's Drug Discovery	55/100
4th	Amydis Diagnostics 2013, San Diego (United States), Series A	Developer of diagnostics test for detection of Alzheimer's disease	$8.69M	NIA, Springboard Enterprises & 4 others	53/100
5th	Todos Medical 2009, Rehovot (Israel), Public	Developer of in vitro diagnostics for the detection of cancer and neurodegenerative disorders	-	Lincoln Park Capital, Yozma & 2 others	47/100
6th	DiamiR 2009, Monmouth Junction (United States), Funding Raised	Developer of minimally invasive diagnostic tests	-	NIA, HHS	45/100
7th	ADmit Therapeutics 2017, Barcelona (Spain), Series A	Provider of diagnostic services for early detection of Alzheimer's disease	$12.9M	Ship2B, Clave & 13 others	42/100
8th	Lucent Diagnostics 2023, Billerica (United States), Unfunded	Developer of a biomarker blood test for the diagnosis of Alzheimer's disease	-	-	40/100
9th	bioLOCKEY Healthworks 2023, Bengaluru (India), Seed	Developer of point-of-care diagnostics and novel biologics by Nanobody discovery platform	$478K	Pfizer, Pfizerindovation & 7 others	37/100
10th	Veravas 2017, Oakdale (United States), Series A	Provider of platform to manage sample preparation and diagnostic solutions	$25M	SeedFunders	37/100